Clinical Trials Browser

Phase 2 × drozitumab × Lymphoid × Clear all

NCT00517049 2017-06-06

A Study of PRO95780 in Combination With Rituximab in Patients With Non-Hodgkin's Lymphoma That Has Progressed Following Previous Rituximab Therapy (APM4083g)

Phase 2 Completed

Lymphoma, Lymphoma, Non-Hodgkin